The Syrian hamster provides unique biological advantages: their immunologically privileged cheek pouch enables robust oncology xenograft studies, and their human-like lipid metabolism make them especially suitable for studies on dyslipidemia and atherosclerosis. BioLegacy leverages these advantages for sponsors’ therapeutic programs in oncology, metabolism, and vascular health. Our expertise employing the distinct traits of this model in GLP and non-GLP studies ensures we deliver the definitive efficacy data required to de-risk and advance your pipelines.
- Oncology & Xenograft Models: Expertise in utilizing the cheek pouch as an ideal, immunologically privileged site for tumor cell implantation and therapeutic assessment without requiring an immunocompromised host.
- Metabolic Disease Research: Robust, diet-induced models of hyperlipidemia and atherosclerosis that closely mimic human lipid metabolism and lipoprotein profiles.
- Comprehensive Bioanalytical Support: Fully integrated in-house services for PK/TK, biomarker discovery, histology, and more.
- AAALAC-Accredited Care: Our state-of-the-art, accredited facilities, and trained, compassionate staff ensure the highest standards of animal welfare and data quality.
